These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26787135)

  • 1. Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients.
    Nishikawa H; Enomoto H; Iwata Y; Kishino K; Shimono Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Ishii A; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Hepatol Res; 2016 Oct; 46(11):1065-1073. PubMed ID: 26787135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-naïve chronic hepatitis B.
    Ishii A; Nishikawa H; Enomoto H; Iwata Y; Kishino K; Shimono Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Hepatol Res; 2017 Feb; 47(2):204-215. PubMed ID: 26990490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study.
    Nishikawa H; Enomoto H; Iwata Y; Kishino K; Shimono Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Ishii A; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    J Viral Hepat; 2016 Dec; 23(12):977-984. PubMed ID: 27476460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis.
    Nishikawa H; Enomoto H; Iwata Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Hepatol Res; 2016 Jun; 46(7):613-21. PubMed ID: 26406984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis.
    Nishikawa H; Enomoto H; Iwata Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Ishii A; Iijima H; Nishiguchi S
    Hepatol Res; 2016 May; 46(6):575-83. PubMed ID: 26418076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Ichikawa Y; Joshita S; Umemura T; Shobugawa Y; Usami Y; Shibata S; Yamazaki T; Fujimori N; Komatsu M; Matsumoto A; Tanaka E
    Hepatol Res; 2017 Feb; 47(2):226-233. PubMed ID: 27029022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients.
    Jekarl DW; Choi H; Lee S; Kwon JH; Lee SW; Yu H; Kim M; Kim Y; Sung PS; Yoon SK
    Ann Lab Med; 2018 Jul; 38(4):348-354. PubMed ID: 29611385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.
    Hasegawa K; Takata R; Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Yuri Y; Nakano C; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA
    Inoue T; Tsuzuki Y; Iio E; Shinkai N; Matsunami K; Fujiwara K; Matsuura K; Nojiri S; Tanaka Y
    Jpn J Infect Dis; 2018 May; 71(3):177-183. PubMed ID: 29491234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients.
    Yeh ML; Huang CF; Huang CI; Dai CY; Lin IH; Liang PC; Hsieh MH; Lin ZY; Chen SC; Huang JF; Chen JJ; Yu ML; Chuang WL
    PLoS One; 2019; 14(8):e0220663. PubMed ID: 31393964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.
    Kim HS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Park YN; Han DH; Kim KS; Choi JS; Choi GH; Kim HS
    Clin Mol Hepatol; 2020 Jan; 26(1):33-44. PubMed ID: 31243939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein level as a diagnostic marker of hepatitis B virus-related hepatocellular carcinoma.
    Chuaypen N; Chittmittraprap S; Pinjaroen N; Sirichindakul B; Poovorawan Y; Tanaka Y; Tangkijvanich P
    Hepatol Res; 2018 Oct; 48(11):872-881. PubMed ID: 29732647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment.
    Cheung KS; Seto WK; Wong DK; Mak LY; Lai CL; Yuen MF
    Oncotarget; 2017 Jul; 8(29):47507-47517. PubMed ID: 28537900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.
    Kim SU; Heo JY; Kim BK; Park JY; Kim DY; Han KH; Ahn SH; Kim HS
    Liver Int; 2017 Jun; 37(6):879-887. PubMed ID: 27973711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis.
    Nishikawa H; Enomoto H; Iwata Y; Kishino K; Shimono Y; Hasegawa K; Nakano C; Takata R; Yoh K; Nishimura T; Aizawa N; Sakai Y; Ikeda N; Takashima T; Ishii A; Iijima H; Nakamura H; Nishiguchi S
    Hepatol Res; 2016 Nov; 46(12):1194-1202. PubMed ID: 26836229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-treatment serum Wisteria floribunda agglutinin-positive mac-2-binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
    Sato S; Tsuzura H; Kita Y; Ikeda Y; Kabemura D; Sato S; Amano N; Yatagai N; Murata A; Shimada Y; Genda T
    JGH Open; 2021 Oct; 5(10):1203-1209. PubMed ID: 34622009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein.
    Sato S; Genda T; Ichida T; Amano N; Sato S; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Hirano K; Shimada Y; Iijima K; Wada R; Nagahara A; Watanabe S
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.
    Heo JY; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Park YN; Ahn SS; Han KH; Kim HS
    Medicine (Baltimore); 2016 Apr; 95(14):e3328. PubMed ID: 27057911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
    Kawanaka M; Tomiyama Y; Hyogo H; Koda M; Shima T; Tobita H; Hiramatsu A; Nishino K; Okamoto T; Sato S; Hara Y; Nishina S; Kawamoto H; Chayama K; Okanoue T; Hino K
    Hepatol Res; 2018 Jun; 48(7):521-528. PubMed ID: 29316028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B.
    Kawaguchi K; Honda M; Ohta H; Terashima T; Shimakami T; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Komura T; Unoura M; Kaneko S
    J Gastroenterol; 2018 Jun; 53(6):740-751. PubMed ID: 28849280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.